Endoscopic Retrograde Cholangiopancreatography Market Size & Growth Forecast 2027–2036, By Segments (End Use, Product, Procedure), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Outpatient Facilities (Largest & Fastest-Growing Segment)

The outpatient facilities segment dominated the endoscopic retrograde cholangiopancreatography (ERCP) market, accounting for the largest market share of 55.21% in 2026, and is also expected to grow at the fastest rate over the forecast period. This growth is driven by the increasing shift toward minimally invasive procedures, shorter hospital stays, and cost-efficient healthcare delivery. Outpatient facilities are increasingly adopting advanced endoscopic technologies to perform diagnostic and therapeutic procedures without requiring prolonged inpatient care. ERCP procedures conducted in these settings enable the management of biliary obstructions, gallstones, and pancreatic disorders while supporting faster patient recovery and efficient utilization of healthcare resources. Improvements in endoscopic imaging, anesthesia techniques, patient monitoring, and post-procedure care are expanding the range of ERCP procedures that can be safely performed in outpatient environments. Additionally, growing demand for ambulatory care, rising healthcare expenditure, and efforts to reduce hospital-associated costs are encouraging healthcare providers to expand outpatient endoscopy services. Increasing availability of skilled gastroenterologists, specialized endoscopy units, and advanced procedural equipment is further supporting adoption. As healthcare systems continue to prioritize convenient, accessible, and efficient treatment pathways, outpatient facilities are expected to remain an important setting for ERCP procedures.

Endotherapy Devices (Largest & Fastest-Growing Segment)

The endotherapy devices segment dominated the ERCP market, accounting for a 40.07% market share in 2026, and is projected to grow at the fastest rate over the forecast period, driven by the increasing use of therapeutic endoscopic interventions for biliary and pancreatic disorders. Endotherapy devices, including sphincterotomes, guidewires, retrieval baskets, dilation balloons, and biliary stents, play a critical role in facilitating minimally invasive treatment of conditions such as bile duct stones, strictures, and obstructions. The growing preference for endoscopic interventions over conventional surgical procedures is supporting demand for advanced devices that improve procedural precision, safety, and treatment outcomes. Technological advancements in device design, enhanced flexibility, improved maneuverability, and better compatibility with endoscopic imaging systems are expanding their clinical utility. In addition, the increasing prevalence of gastrointestinal and hepatobiliary disorders, along with rising demand for effective treatment options that minimize recovery time, is encouraging greater utilization of endotherapy devices. Growing investments in endoscopy infrastructure, expanding access to specialized gastroenterology services, and continuous improvements in therapeutic device technologies are further supporting segment growth. The increasing emphasis on successful stone extraction, effective drainage, and reduced procedure-related complications is expected to sustain demand for advanced ERCP endotherapy devices.

Biliary Sphincterotomy (Largest & Fastest-Growing Segment)

In 2026, the biliary sphincterotomy segment accounted for the largest market share of 20.9% in the ERCP market and is expected to grow at the fastest rate over the forecast period, supported by its widespread application in the treatment of biliary disorders. Biliary sphincterotomy involves making a controlled incision in the sphincter of oddi to facilitate access to the bile duct, enabling the removal of bile duct stones, placement of stents, and management of biliary obstructions. Its established role in therapeutic ERCP procedures makes it an important intervention for patients with choledocholithiasis, biliary strictures, and other conditions affecting bile flow. The growing prevalence of gallstone-related disorders and increasing diagnosis of biliary diseases are contributing to the demand for effective endoscopic treatment approaches. Biliary sphincterotomy also supports the use of complementary endotherapy techniques, including stone extraction, balloon dilation, and biliary drainage, allowing physicians to address multiple clinical requirements within a single procedure. Advancements in electrosurgical technologies, endoscopic visualization, and procedural techniques are helping improve precision and support safer interventions. Furthermore, the growing preference for minimally invasive treatment, shorter recovery periods, and reduced need for open surgery is encouraging the adoption of biliary sphincterotomy. Expanding access to specialized endoscopy services and increasing clinical expertise in therapeutic ERCP are expected to further support the segment's growth.